Comhábhair Ghníomhach Cógaisíochta
| Progestogen agus estrogen | |||
| Ainm Táirge | Sonraíocht | Ceadaithe | CAS Uimh. |
| Progesterone | CP/PE/USP/JP | CEP/EU-GMP/FDA | 57-83-0 |
| Pregnenolone | In-tí |
Kosher | 145-13-1 |
| Medroxyprogesterone Aicéatáit | CP/PE/USP/JP | DMF/GMP | 71-58-9 |
| Aicéatáit Megestrol | CP/PE/USP | DMF i bpróiseas | 595-33-5 |
| Mifepristone | CP/IP | DMF/GMP | 84371-65-3 |
| Aicéatáit Cyproterone | CP/PE/IP/KP | CEP/TGA/EU-GMP | 427-51-0 |
| Levonorgestrel | CP/PE/USP/IP | CEP/GMP | 797-63-7 |
| Norethisterone |
CP/PE/USP/JP |
DMF i bpróiseas |
68-22-4 |
| Aicéatáit Norethisterone |
EP/USP |
DMF i bpróiseas |
51-98-9 |
| Norethisterone Enanthate |
In-tí |
Faoi T&F |
3836-23-5 |
| Drospirenone | EP/USP | DMF | 67392-87-4 |
| Gestóidéin | CP/PE | DMF/GMP | 60282-87-3 |
| Estradiol | CP/PE/USP/KP | DMF/GMP/WC | 35380-71-3 |
| Estriol | CP/PE/USP | Faoi T&F | 50-27- 1 |
| Ethinyl Estradiol | CP/PE/USP | GMP | 57-63-6 |
| Valerate Estradiol | CP/PE/USP/KP | DMF | 979-32-8 |
| Estradiol Cypionate |
USP | DMF i bpróiseas |
313-06-4 |
| Promestrene |
In-tí |
Faoi T&F |
39219-28-8 |
| Tibolone | CP/PE | DMF/GMP | 5630-53-5 |
| Dienogest | PE | CEP/GMP | 65928-58-7 |
| Fulvestrant | EP/USP | Faoi T&F | 129453-61-8 |
| Exemestane | CP/PE/USP | Faoi T&F | 107868-30-4 |
| Androgen | |||
| Ainm Táirge | Sonraíocht | Ceadaithe | CAS Uimh. |
| Finasteride | CP/PE/USP | CEP/FDA/PMDA/GMP | 98319-26-7 |
| Dutasteride | EP/USP | CEP/FDA | 164656-23-9 |
| Aicéatáit Abiraterone | CP/USP | DMF/GMP/WC | 154229-18-2 |
| Darolutamide |
In-tí |
Faoi T&F |
1297538-32-9 |
| Testosterone | CP/PE/USP | CEP/FDA/WC | 58-22-0 |
| Testosterone Undecanoate | CP | DMF/WC | 5949-44-0 |
| Testosterone Cypionate | USP | DMF | 58-20-8 |
| Testosterone Enanthate |
USP/JP | Faoi T&F |
315-37-7 |
| Testosterone Propionate |
CP/PE/USP/JP |
Faoi T&F |
57-85-2 |
| DHEA | FP/In-tí | DMF/WC/Kosher | 53-43-0 |
| Clascoterone | In-tí | DMF i bpróiseas | 19608-29-8 |
| Hormone Cortical | |||
| Ainm Táirge | Sonraíocht | Ceadaithe | CAS Uimh. |
| Budesonide | CP/PE/USP/JP | CEP/FDA/GMP | 51333-22-3 |
| Desonide | CP/USP | DMF/GMP | 638-94-8 |
| Eplerenone | PE | CEP ar siúl | 107724-20-9 |
| Methylprednisolone | CP/PE/USP/JP | DMF/GMP | 83-43-2 |
| Methylprednisolone Hemisuccinate | CP/PE/USP | DMF/GMP | 2921-57-5 |
| Fluticasone Propionate | CP/PE/USP | DMF | 80474- 14-2 |
| Fluticasone Furoate | CP/PE | DMF i bpróiseas | 397864-44-7 |
| Mometasone Furoate |
CP/PE/USP |
DMF i bpróiseas |
Ainhidriúil (83919-23-7) Monahiodráit (141646-00-6) |
| Deflazacort |
In-tí |
Faoi T&F |
14484-47-0 |
| Daoine eile | |||
| Ainm Táirge | Sonraíocht | Ceadaithe | CAS Uimh. |
| Oxcarbazepine | CP/PE/USP/IP | CEP/FDA/GMP | 28721-07-5 |
| Aicéatáit Eslicarbazepine | CP/USP | DMF | 236395- 14-5 |
| Ganciclovir | CP/PE/USP | DMF/GMP | 82410-32-0 |
| Valganciclovir Hidreaclóiríd | USP/EP | CEP ar siúl | 175865-59-5 |
| Fosfáit Oseltamivir | CP/PE/USP | DMF | 204255- 11-8 |
| Baloxavir Marboxil | In-tí | Faoi T&F | 1985606-14-1 |
| Revefenacin | In-tí | DMF | 864750-70-9 |
| Mireabóg | CP/PE | DMF | 223673-61-8 |
| Vibegron |
In-tí |
Faoi T&F |
1190389-15-1 |
| Escitalopram Oxalate | CP/PE/USP | DMF i bpróiseas | 219861-08-2 |
| Citalopram Hidreabrómide |
CP/PE/USP |
DMF i bpróiseas |
59729-32-7 |
| Hidreaclóiríd Cariprazine | In-tí | DMF | 1083076-69-0 |
| Lasmiditan Succinate | In-tí | DMF | 439239-92-6 |
| Luliconazole | In-tí | DMF | 187164-19-8 |
| Esylate Nintedanib |
In-tí |
FDA/DMF/WC |
656247-18-6 |
| Apalutami | In-tí | DMF | 956104-40-8 |
| Tadalafil | CP/PE/USP | Faoi T&F | 171596-29-5 |
| Relugolix | In-tí | DMF i bpróiseas | 737789-87-6 |
| fosfáit ruxolitinib |
In-tí |
DMF i bpróiseas |
1092939-17-7 |
| Abemaciclib |
In-tí |
Faoi T&F |
1231929-97-7 |
| Phloroglucinol | CP/PE | DMF | 108-73-6 |
| 1,3,5-Trimethoxybenzene |
CP/In-tí |
GMP |
621-23-8 |
| Aigéad Ursodeoxycholic | PE/USP/JP | Faoi T&F | 128-13-2 |
| Aigéad Tauroursodeoxycholic |
In-tí |
Faoi T&F |
14605-22-2 |
| Cholesterol |
CP/PE/USP/JP |
Faoi T&F |
57-88-5 |
| Éitear eitile Omega-3-Aigéad 90 |
EP/USP |
DMF i bpróiseas |
—— |
| Tríghlicrídí meánshlabhra |
CP/USP/EP |
DMF |
—— |
| Clóiríd Benzalkonium |
USP/EP/JP |
CEP ar siúl |
8001-54-5 |
| Ola olóige (Le Instealladh) |
CP/USP/PE/JP |
DMF i bpróiseas |
8001-25-0 |
| Fosfailipidí uibheacha (Le Instealladh) |
CP/USP/EP |
DMF |
93685-90-6 |
| Snack |
In-tí |
DMF i bpróiseas |
203787-91-1 |
Tá sonraíochtaí CP, USP ag Aicéatáit Abiraterone. DMF, leithreas ar fáil.
Tá sonraíochtaí EP, USP ag Drospirenone. DMF ceadaithe.
Tá Aicéatáit Medroxyprogesterone ag USPã EPã IPã JP agus KP. Tá DMF, GMP ar fáil.
Tá sonraíochtaí CP, EP agus USP.CEP agus DMF ar fáil ag Oxcarbazepine, ceadaithe ag GMP.
Tá CP, PE, USP specification.DMF agus GMP ceadaithe ag Ganciclovir.
Tá sonraíocht intí.DMF ar fáil ag Nintedanib Esylate.